Lumos Diagnostics Secures $8.89m funding through Hologic
- Lumos Diagnostics (LDX) signs three new agreements to secure US$5.9 million (A$8.89 million) in funding
- The company entered a sale and leaseback agreement with US-based women’s healthcare company Hologic, which will purchase some of Lumos’ capital equipment in return for US$4.2 million (A$6.3 million)
- Additionally, Hologic signed two further agreements worth up to US$1.7 million to undertake additional work on existing projects
- These contracts follow the three service agreements between Hologic and Lumos signed during the first half of FY2023
- LumosDiagnostics shares are trading at 3.1 cents at 1:40 pm AEDT
